Loading asset research
Greenland Mines Ltd. Common Stock
GRMLNasdaq · USD · StocksQuote as of · Exchange session not verified$3.14
-17.67%
Today
GRML
Loading 1D prices…
Market cap
$10M
Volume
859.9K
52w high
$11.6652w low
$0.156Company profile
Greenland Mines Ltd. Common Stock
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Charlotte, NC, United States
Employees
5
Fiscal year end
1231
CIK
1907223
Session & valuation
Open$3.82
Previous close$3.82
Day high$3.95
Day low$3.13
30-day avg. volume4.9M
Outstanding shares158.9M
Diluted EPS-$0.22
Latest annual period
P/E (trailing)-14.30
P/E (forward)—
Price / book0.17
Beta2.48
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SNTISenti Biosciences Holdings Inc. Common Stock | $9.5M | $22K | -279263.64% | -$2.73 | +2.00% | Buy |
| INABIN8bio Inc. Common Stock | $10.5M | $0.00 | — | -$4.44 | -2.73% | Buy |
| AIMAIM ImmunoTech Inc. Common Stock | $8.3M | $88K | -15861.36% | -$8.62 | -2.65% | Buy |
| INTSIntensity Therapeutics Inc. Common stock | $13.1M | $0.00 | — | -$8.56 | -0.50% | Buy |
| PLURPluri Inc. Common Stock | $14.6M | $1M | -2344.59% | -$2.44 | -5.60% | Unrated |